Wearable Movement Sensors for Assessing Motor Impairments and Dyskinesias in Parkinson Disease
Status: | Completed |
---|---|
Conditions: | Parkinsons Disease |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | Any |
Updated: | 4/21/2016 |
Start Date: | January 2012 |
End Date: | June 2013 |
The purpose of this study is to measure motor fluctuations and dyskinesias in patients with
Parkinson's disease using movement sensors (accelerometers and gyroscopes) to determine if
this is a feasible measure to use in addition to self report, and eventually the goal will
be to replace self report with a more reliable measure such as movement sensors.
Parkinson's disease using movement sensors (accelerometers and gyroscopes) to determine if
this is a feasible measure to use in addition to self report, and eventually the goal will
be to replace self report with a more reliable measure such as movement sensors.
Patients with Parkinson disease and motor fluctuations will wear movement sensors during
their regular clinic visit with the principal investigator. The visit will be videotaped and
medication status (ON without dyskinesia, ON with dyskinesia, or OFF) will be independently
rated from review of the video.
their regular clinic visit with the principal investigator. The visit will be videotaped and
medication status (ON without dyskinesia, ON with dyskinesia, or OFF) will be independently
rated from review of the video.
Inclusion Criteria:
- Participants who will be included in the study have probable or definite idiopathic
PD (CAPSIT criteria (23)), Hoehn & Yahr stage 2-4;
- One or more of the following PD-associated motor impairments experienced in the week
prior to enrollment (based on history and/or examination): motor fluctuations (end of
dose wearing off with hypokinesia and/or levodopa-induced choreiform dyskinesias),
tremor, freezing of gait, or frequent falls (≥ 1 per week).
Exclusion Criteria:
- Neurological disorders (other than PD) or orthopedic deficits that, in the
investigator's judgement, contribute substantially to impaired movement (e.g. stroke
with motor sequelae;
- Essential tremor;
- Severe osteoarthritis);
- Cognitive impairment sufficiently severe to interfere with informed consent.
We found this trial at
1
site
University of Rochester The University of Rochester is one of the country's top-tier research universities....
Click here to add this to my saved trials